Clinical Trial Update: Efficacy and Safety of BIIL 284 BS in Adult Patients With Active Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of BIIL 284 BS in adults with active rheumatoid arthritis completed, with results on efficacy and safety report…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• BIIL 284 BS

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED